An entacapone-containing oral dosage form

Details for Australian Patent Application No. 2006256724 (hide)

Owner Orion Corporation

Inventors Vahervuo, Kari

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006256724

PCT Pub. Number WO2006/131591

Priority 60/688,334 08.06.05 US

Filing date 7 June 2006

Wipo publication date 14 December 2006

Acceptance publication date 7 June 2012

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/195 (2006.01)

A61K 31/275 (2006.01) - Nitriles

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/131591 Priority application(s): WO2006/131591

7 June 2012 Application Accepted

  Published as AU-B-2006256724

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006256738-3 -aryloxy8 -aza-bicyclo (3.2.1.) oct6- ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

2006256723-Alarm system and alarm device